LeMaitre Vascular
LMAT
156 hedge funds and large institutions have $617M invested in LeMaitre Vascular in 2018 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 68 increasing their positions, 48 reducing their positions, and 18 closing their positions.
42% more repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 48
27% more capital invested
Capital invested by funds: $486M → $617M (+$131M)
2% more ownership
Funds ownership: 79.92% → 81.91% (+2%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less funds holding
Funds holding: 166 → 156 (-10)
50% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
+$7.73M |
| 2 |
BlackRock
New York
|
+$4.31M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$3.98M |
| 4 |
State Street
Boston,
Massachusetts
|
+$2.98M |
| 5 |
SCA
Summit Creek Advisors
Minneapolis,
Minnesota
|
+$2.85M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EIP
Epoch Investment Partners
New York
|
-$3.53M |
| 2 |
Millennium Management
New York
|
-$2.25M |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$1.82M |
| 4 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
-$1.58M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.53M |
LMAT Hedge Fund Activity: Q3 2018 in Review
156 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q3 2018, worth a combined $617M — up 27% from $486M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of LMAT and 9 opened new positions — a net loss of 9 holders — while 48 trimmed existing stakes and 68 added.
The largest buyer was Conestoga Capital Advisors, adding an estimated $7.73M. The largest seller was Epoch Investment Partners, cutting an estimated $3.53M.
- 156 institutional investors held LeMaitre Vascular (LMAT) as of Q3 2018, down from 166 in Q2 2018.
- Funds reported $617M of LeMaitre Vascular stock for Q3 2018, up 27% quarter-over-quarter.
- 9 funds opened new LeMaitre Vascular positions in Q3 2018 and 18 closed out, a net change of -9 holders.
- The largest LeMaitre Vascular buyer in Q3 2018 was Conestoga Capital Advisors, an estimated $7.73M added.
- The largest LeMaitre Vascular seller in Q3 2018 was Epoch Investment Partners, an estimated $3.53M sold.
Based on aggregated 13F filings for Q3 2018.